bexarotene regulates Amyloid beta
Evidence from:
primary |
all sources
Evidence (2 sources)
bexarotene reduced CNS Aβ levels
confidence: 0.94
New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy.
(2014)
PMID:25368578
cited
bexarotene ... stimulated the ApoE-dependent Aβ clearance in AD model mice
confidence: 0.92